March 2, 2026 - Regulatory SynAct Pharma has carried out a directed issue of new shares of approximately 51.9 MSEK
March 2, 2026 - Regulatory SynAct Pharma announces intention to carry out a directed issue of approximately 45 MSEK
January 9, 2026 - Regulatory The Board of Directors of SynAct Pharma AB (publ) has resolved on the repurchase of own shares
